ATF4 and lung carcinoma: RPL41 promotes ATF4 translocation to the cytoplasm, increases the ATF4 phosphorylation, thus accelerating ATF4 degradation and sensitizing lung cancer and retinoblastoma cells to chemotherapeutic drugs [71].